Evidence map›Paper›PMID 33482878›Full record

ArticleTrials2021

The acupoint herbal plaster for the prevention and treatment of postoperative nausea and vomiting after PLIF with general anesthesia: study protocol for a multicenter randomized controlled trial.

Huiqing Xu, Xu Wei, Ranxing Zhang, Ling Li, Zhijun Zhang, Ruo Jia, Xiaofei Zhang, Xiumei Gao, Xicheng Dong, Junjun Pan

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Huiqing Xu *Department of Anesthesiology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, China.
Xu Wei *Department of Scientific Research, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, China.
Ranxing ZhangDepartment of Clinical Laboratory, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, China.
Ling LiDepartment of Anesthesiology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, China.
Zhijun ZhangDepartment of Anesthesiology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, China.
Ruo JiaDepartment of Anesthesiology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, China.
Xiaofei ZhangDepartment of Anesthesiology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, China.
Xiumei GaoDepartment of Anesthesiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.
Xicheng DongDepartment of Anesthesiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Junjun PanTCM Characteristic Clinical Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, 100102, Beijing, China. jojopan128@163.com.ORCID http://orcid.org/0000-0002-6424-945X
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

China Academy of Chinese Medical Sciences ZZ11-033
6 · The paper itself

Abstract

backgroundPostoperative nausea and vomiting (PONV) are common in posterior lumbar intervertebral fusion (PLIF) patients undergoing general anesthesia. The previous clinical observation has shown that a traditional acupoint herbal plaster (AHP) is beneficial to patients with PONV. This trial aims to assess the effect of the AHP for the prevention and treatment of PONV after PLIF in patients with general anesthesia.

methodsA multicenter, parallel, randomized controlled trial (RCT) will be conducted. A total of 166 participants will be randomized to either a treatment group receiving an AHP or a control groups receiving an acupoint placebo plaster (APP) in a 1:1 ratio. The primary outcomes are the first occurrence and frequency of nausea and vomiting. The secondary outcomes include the severity grading of nausea and vomiting using a visual analog scale (VAS) measurement system, quality of life, and serological indicators. The safety evaluation is mainly about adverse events and skin reactions' observation. Assessments will be carried out at the baseline, day 1, and day 2 (the end of the intervention). The central randomization system in the clinical trial ( http://124.205.181.142:8082/xwtf/ ) will be used to conduct random allocation. DISCUSSION: This scientific methodology design of the trial is expected to provide clinical evidence to support the AHP for the prevention and treatment of PONV.

trial registrationThis study is retrospectively registered with the Chinese Clinical Trial Registry ( http://www.chictr.org.cn ) on 19 April 2018. ID: ChiCTR1800015768.

Indexed as

AntiemeticsTranscutaneous Electric Nerve StimulationAcupuncture PointsAnesthesia, GeneralHumansMulticenter Studies as TopicPain MeasurementPostoperative Nausea and VomitingRandomized Controlled Trials as TopicAntiemeticsAcupoint herbal plasterChinese medicinePostoperative nausea and vomitingRandomized controlled trial

Identifiers

PMID33482878
PMCPMC7821521
OpenAlexW3124257085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.